未登录

R

Richard N. Upton

university of south australia

H指数:40

被引数:6,975

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnostic and prognostic evaluation of an echocardiography-based artificial intelligence algorithm for detecting HFpEF: a case-control analysis

EUROPEAN HEART JOURNAL

IF35.6

2024-10-280

PRE

Treatment Targets Should Influence Choice of Infliximab Dose Intensification Strategy in Inflammatory Bowel Disease: A Pharmacokinetic Simulation Study

IF6.9

2024-08-220

OAAI

Pharmacokinetic-pharmacodynamic modelling and simulation of methotrexate dosing in patients with rheumatoid arthritis

类风湿关节炎患者甲氨蝶呤给药的药代动力学-药效学模型和模拟

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2024-07-050

OA

Getting the Dose Right-Revisiting the Topic With Focus on Biologic Agents

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2024-04-283

PRE

Combining the potential of 3D printed buccal films and nanostructured lipid carriers for personalised cannabidiol delivery

结合3D打印颊膜和纳米结构脂质载体的潜力，用于个性化大麻二酚递送

DRUG DELIVERY AND TRANSLATIONAL RESEARCH

IF5.5

2023-10-3010

OAAI

Dynamic exposure and body burden models for per- and polyfluoroalkyl substances (PFAS) enable management of food safety risks in cattle

ENVIRONMENT INTERNATIONAL

IF9.7

2023-10-015

OAAI

Spatio-temporal trends in livestock exposure to per- and polyfluoroalkyl substances (PFAS) inform risk assessment and management measures

ENVIRONMENTAL RESEARCH

IF7.7

2023-05-0111

OAAI

3D printed bilayer mucoadhesive buccal film of estradiol: Impact of design on film properties, release kinetics and predicted in vivo performance

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2022-11-0117

PRE

Mucoadhesive Buccal Film of Estradiol for Hormonal Replacement Therapy: Development and In-Vivo Performance Prediction

IF5.5

2022-02-2818

OAAI

3D Printing of Thermo-Sensitive Drugs

IF5.5

2021-09-2135

OAAI

Demonstrating Contribution of Components of Fixed-Dose Drug Combinations Through Longitudinal Exposure-Response Analysis

通过纵向暴露-反应分析证明固定剂量药物组合成分的贡献

IF3.7

2020-01-272

PREAI

Population pharmacokinetics of lenalidomide in patients with B-cell malignancies

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2019-02-279

OAAI

Dashboards for Therapeutic Monoclonal Antibodies: Learning and Confirming

IF3.7

2018-06-1416

OAAI

Infliximab Maintenance Dosing in Inflammatory Bowel Disease: an Example for In Silico Assessment of Adaptive Dosing Strategies

IF3.7

2017-04-2530

PREAI

Population Pharmacokinetic Model of Doxycycline Plasma Concentrations Using Pooled Study Data

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

IF4.5

2017-03-019

OA

Pharmacokinetic models of morphine and its metabolites in neonates: Systematic comparisons of models from the literature, and development of a new meta-model

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2016-09-0130

OAAI

A Quantitative Review and Meta-Models of the Variability and Factors Affecting Oral Drug Absorption-Part I: Gastrointestinal pH

IF3.7

2016-08-05104

PREAI

A Quantitative Review and Meta-models of the Variability and Factors Affecting Oral Drug Absorption-Part II: Gastrointestinal Transit Time

IF3.7

2016-07-2031

PREAI

Population In Vitro-In Vivo Correlation Model Linking Gastrointestinal Transit Time, pH, and Pharmacokinetics: Itraconazole as a Model Drug

PHARMACEUTICAL RESEARCH

IF4.3

2016-04-2727

PREAI

A model-based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activity

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2016-04-070

OAAI